Josh Jennings
Stock Analyst at TD Cowen
(3.53)
# 2,671
Out of 4,598 analysts
1114
Total ratings
46.8%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterated: Buy | $100 → $117 | $92.80 | +26.08% | 52 | Aug 3, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $120 | $81.55 | +47.15% | 70 | Aug 2, 2026 | |
| VCEL Vericel | Reiterated: Buy | $55 → $58 | $46.05 | +25.95% | 24 | Jul 31, 2026 | |
| BAX Baxter International | Maintained: Hold | $24 → $29 | $28.10 | +3.20% | 39 | Jul 31, 2026 | |
| CERS Cerus | Reiterated: Buy | $5 | $2.15 | +132.56% | 37 | Jul 31, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $61 → $56 | $48.43 | +15.63% | 80 | Jul 30, 2026 | |
| DXCM DexCom | Reiterated: Buy | $95 | $87.31 | +8.81% | 41 | Jul 30, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $115 | $107.12 | +7.36% | 73 | Jul 28, 2026 | |
| EW Edwards Lifesciences | Rated: Buy | $104 | $88.82 | +17.09% | 72 | Jul 23, 2026 | |
| MDT Medtronic | Reiterated: Buy | $119 → $100 | $86.68 | +15.37% | 71 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $12 | $4.62 | +159.74% | 33 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.28 | +81.16% | 11 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.22 | -27.01% | 32 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $1.25 | $0.6893 | +81.34% | 46 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.23 | - | 13 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $18.31 | +58.38% | 23 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $18.38 | +84.98% | 30 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $163 | $170.21 | -4.24% | 21 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.22 | +75.81% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.33 | +275.94% | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.12 | +264.08% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.99 | +100.40% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $254.41 | -1.73% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $20 | $10.15 | +97.04% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $169.70 | +123.34% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $341.20 | +27.49% | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.07 | - | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $4.14 | +2,073.91% | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $20.11 | -0.55% | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $99 | $96.98 | +2.08% | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2698 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3681 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25.26 | $10.38 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $13 | $0.8669 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $131.15 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $1.25 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.61 | n/a | 1 | Mar 18, 2015 |
Establishment Labs Holdings
Aug 3, 2026
Reiterated: Buy
Price Target: $100 → $117
Current: $92.80
Upside: +26.08%
TransMedics Group
Aug 2, 2026
Maintained: Buy
Price Target: $120
Current: $81.55
Upside: +47.15%
Vericel
Jul 31, 2026
Reiterated: Buy
Price Target: $55 → $58
Current: $46.05
Upside: +25.95%
Baxter International
Jul 31, 2026
Maintained: Hold
Price Target: $24 → $29
Current: $28.10
Upside: +3.20%
Cerus
Jul 31, 2026
Reiterated: Buy
Price Target: $5
Current: $2.15
Upside: +132.56%
Boston Scientific
Jul 30, 2026
Maintained: Buy
Price Target: $61 → $56
Current: $48.43
Upside: +15.63%
DexCom
Jul 30, 2026
Reiterated: Buy
Price Target: $95
Current: $87.31
Upside: +8.81%
Abbott Laboratories
Jul 28, 2026
Maintained: Buy
Price Target: $115
Current: $107.12
Upside: +7.36%
Edwards Lifesciences
Jul 23, 2026
Rated: Buy
Price Target: $104
Current: $88.82
Upside: +17.09%
Medtronic
Jul 10, 2026
Reiterated: Buy
Price Target: $119 → $100
Current: $86.68
Upside: +15.37%
Jun 30, 2026
Maintained: Buy
Price Target: $5.5 → $12
Current: $4.62
Upside: +159.74%
Jun 29, 2026
Reiterated: Buy
Price Target: $15
Current: $8.28
Upside: +81.16%
Jun 18, 2026
Maintained: Buy
Price Target: $6
Current: $8.22
Upside: -27.01%
Jun 17, 2026
Reiterated: Buy
Price Target: $1.5 → $1.25
Current: $0.6893
Upside: +81.34%
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $5.23
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $29
Current: $18.31
Upside: +58.38%
Jun 1, 2026
Reiterated: Buy
Price Target: $34
Current: $18.38
Upside: +84.98%
May 29, 2026
Reiterated: Hold
Price Target: $163
Current: $170.21
Upside: -4.24%
May 27, 2026
Reiterated: Buy
Price Target: $25
Current: $14.22
Upside: +75.81%
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.33
Upside: +275.94%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
May 8, 2026
Rated: Buy
Price Target: $12 → $10
Current: $4.99
Upside: +100.40%
Apr 23, 2026
Maintained: Buy
Price Target: $250
Current: $254.41
Upside: -1.73%
Jan 23, 2026
Maintained: Buy
Price Target: $27 → $20
Current: $10.15
Upside: +97.04%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $169.70
Upside: +123.34%
Nov 13, 2025
Maintained: Buy
Price Target: $435
Current: $341.20
Upside: +27.49%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.07
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: $90
Current: $4.14
Upside: +2,073.91%
Nov 6, 2025
Maintained: Buy
Price Target: $20
Current: $20.11
Upside: -0.55%
Nov 5, 2025
Maintained: Hold
Price Target: $104 → $99
Current: $96.98
Upside: +2.08%
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.2698
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $0.3681
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $25.26
Current: $10.38
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $15 → $13
Current: $0.8669
Upside: n/a
Oct 29, 2020
Maintained: Buy
Price Target: $80
Current: $131.15
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $1.25
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Maintained: Buy
Price Target: $9
Current: $1.61
Upside: n/a